Celgene Corporation (CELG) financial statements (2021 and earlier)

Company profile

Business Address 86 MORRIS AVENUE
SUMMIT, NJ 07901
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,8979,3237,6914,7304,3783,4102,887
Cash and cash equivalents9,6047,2145,4334,2342,4801,5032,819
Short-term investments1,2932,1092,2584961,8981,90768
Receivables2,3742,4512,3272,0662,1202,0641,991
Inventory, net of allowances, customer advances and progress billings451464442458510555536
Inventory451464442458510555536
Other current assets732445521501819824605
Other undisclosed current assets   1,312  1,853
Total current assets:14,45412,68310,9819,0677,8276,8537,872
Noncurrent Assets
Property, plant and equipment1,4151,4001,3831,3671,3131,2921,251
Intangible assets, net (including goodwill)24,39023,99424,10424,21624,34624,47424,617
Goodwill8,0038,0038,0038,0038,0048,0048,018
Intangible assets, net (excluding goodwill)16,38715,99116,10116,21316,34216,47016,599
Other noncurrent assets1,1041,1061,171830729825816
Total noncurrent assets:26,90926,50026,65826,41326,38826,59126,684
TOTAL ASSETS:41,36339,18337,63935,48034,21533,44434,556
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,4673,6423,3872,9873,1022,9413,046
Accounts payable421327340418292294320
Accrued liabilities2,9643,0352,9752,9872,7052,6152,672
Taxes payable8228072 1053254
Other undisclosed accounts payable and accrued liabilities   (418)   
Deferred revenue4443 
Debt1,498 5005015021,497 
Deferred revenue and credits69
Contract with customer, liability687379  
Other undisclosed current liabilities   496 64 
Total current liabilities:5,0093,6853,9554,0573,6834,5023,115
Noncurrent Liabilities
Long-term debt and lease obligation204225 19,769   
Long-term debt, excluding current maturities   19,769   
Operating lease, liability204225 
Liabilities, other than long-term debt3,1242,9815,7385,4935,9305,6955,998
Deferred revenue and credits35
Accounts payable and accrued liabilities2,4542,2562,2322,1902,4512,3682,514
Deferred revenue1640 
Contract with customer, liability767374  
Deferred tax liabilities, net2,7142,7532,8112,7712,777
Other liabilities654685716477594556672
Other undisclosed noncurrent liabilities20,93922,24119,781 19,74219,81720,271
Total noncurrent liabilities:24,26725,44725,51925,26225,67225,51226,269
Total liabilities:29,27629,13229,47429,31929,35530,01429,384
Stockholders' equity
Stockholders' equity attributable to parent12,08710,0518,1656,1614,8603,4305,172
Common stock10101010101010
Treasury stock, value(26,334)(26,331)(26,298)(26,336)(26,315)(25,700)(22,946)
Additional paid in capital16,07215,75315,38114,97814,75613,83514,077
Accumulated other comprehensive loss(27)(56)(32)(50)(77)(119)(328)
Retained earnings22,36620,67519,10417,55916,48615,40414,359
Other undisclosed stockholders' equity(12,114)(10,107)(8,197)(6,211)(4,937)(3,549)(5,500)
Total stockholders' equity:(27)(56)(32)(50)(77)(119)(328)
Other undisclosed liabilities and equity12,11410,1078,1976,2114,9373,5495,500
TOTAL LIABILITIES AND EQUITY:41,36339,18337,63935,48034,21533,44434,556

Income statement (P&L) ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Revenues4,5204,4004,0254,0373,8923,8143,538
Revenue, net3,538
Cost of revenue(276)(260)(249)(296)(284)(253)(222)
Cost of goods and services sold(167)(151)(140)(169)(157)(126)(135)
Other undisclosed gross profit   452   
Gross profit:4,2444,1403,7764,1933,6083,5613,316
Operating expenses(1,980)(2,029)(2,066)(1,934)(1,928)(2,075)(3,098)
Other undisclosed operating loss   (452)   
Operating income:2,2642,1111,7101,8071,6801,486218
Nonoperating income (expense)(157)(98)296(500)(109)13978
Investment income, nonoperating453834158913
Other nonoperating income (expense)(202)(136)262(515)(117)4965
Interest and debt expense(190)(192)(192)(190)(193)(192)(166)
Income from continuing operations before income taxes:1,9171,8211,8141,1171,3781,3071,030
Income tax expense(226)(250)(269)(44)(296)(262)(184)
Net income available to common stockholders, diluted:1,6911,5711,5451,0731,0821,045846

Comprehensive Income ($ in millions)

9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
Net income:1,6911,5711,5451,0731,0821,045846
Other comprehensive income (loss)29(24)182742209(45)
Comprehensive income, net of tax, attributable to parent:1,7201,5471,5631,1001,1241,254801

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: